Acutus Medical(US:AFIB)2023-03-24 16:01Market Overview - The electrophysiology market is projected to grow at a compound annual growth rate (CAGR) of approximately 11% from 2018 to 2025 [7] - Despite nearly 1 million procedures performed in 2020, the market remains under 5% penetrated [7] - Complex ablations represent 35-40% of procedures and over $3 billion in market opportunity [8] Clinical Studies & Results - The UNCOVER AF study reported 73% freedom from atrial fibrillation (AF) at 12 months in patients treated with PVI + AcQMap-enabled ablation [30] - Patients were approximately 9 times more likely to be in sinus rhythm at 12 months with PVI plus 3+ AcQMap targets ablated [31] - Over 6,000 patients have been treated with AcQMap since its launch [34] Financial Performance & Outlook - Full year 2022 revenue was $164 million, a decrease of 5% compared to the prior year [42] - Full year 2022 non-GAAP operating expenses were $715 million, an increase of 18% compared to the prior year [44] - Full year 2022 disposables revenue was $129 million, an increase of 8% compared to the prior year (11% excluding FX) [45] - The company anticipates modest year-over-year revenue growth for Q1 2023 and projects full-year 2023 revenue between $18 million and $21 million [47]